Access earnings results, analyst expectations, report, slides, earnings call, and transcript.

The company's strategic focus on biomarker-driven approaches and strong clinical trial results in HER2-positive cancers indicate promising developments. The extension of the cash runway into 2027 and the Sanofi collaboration further enhance the outlook. Despite some uncertainties in execution and supply chain risks, the positive clinical data and strategic partnerships suggest a positive market reaction.
The earnings call summary reflects strong financial performance with extended cash runway, improved response rates, and significant market opportunities. The Q&A section highlights positive sentiment from investigators and a clear path forward without FDA delays. Despite some management ambiguities, the overall outlook remains optimistic, bolstered by promising trial results and substantial market potential. These factors suggest a positive stock price movement over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.